Mycostatin and Solu-cortef drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Mycostatin (nystatin) and Solu-cortef (hydrocortisone sodium succinate). Common drug interactions include encephalopathy among females and pneumonia among males.
The phase IV clinical study analyzes what interactions people have when they take Mycostatin and Solu-cortef. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.
What is Mycostatin?
Mycostatin has active ingredients of nystatin. eHealthMe is studying from 4,144 Mycostatin users. Check the latest studies of Mycostatin.
What is Solu-cortef?
Solu-cortef has active ingredients of hydrocortisone sodium succinate. eHealthMe is studying from 7,983 Solu-cortef users. Check the latest studies of Solu-cortef.
29 people who take Mycostatin and Solu-cortef together, and have interactions are studied.

What are the common drug interactions of Mycostatin and Solu-Cortef, by gender? *:
female:
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Renal tubular necrosis (death of kidney tubules)
- Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
- Confusional state
- Hallucination (an experience involving the perception of something not present)
- Anaphylactic reaction (serious allergic reaction)
- Multi-organ failure (multisystem organ failure)
- Pneumonia cytomegaloviral (cmv pneumonia is caused by a member of a group of herpes-type viruses)
- Pneumonitis (inflammation of the walls of the alveoli in the lungs)
- Renal failure (kidney dysfunction)
male:
- Pneumonia
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Ileus (a painful obstruction of the ileum or other part of the intestine)
- Pleural effusion (water on the lungs)
- Pulmonary oedema (fluid accumulation in the lungs)
- Pyrexia (fever)
- Respiratory disorder (respiratory disease)
- Respiratory distress (difficulty in breathing)
- Septic shock (shock due to blood infection)
- Suicidal ideation
What are the common drug interactions of Mycostatin and Solu-Cortef, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Abdominal pain upper
- Cough
- Diarrhoea
- Eye pain
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Pruritus (severe itching of the skin)
- Rash
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
- Rash pustular (redness with pustules)
- Rhinorrhoea (watery mucus discharge from the nose)
10-19:
- C-reactive protein increased
- Exanthem (rashes on skin by viral infection)
- Infection
- Pyrexia (fever)
20-29:
n/a
30-39:
- Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
- Confusional state
- Hallucination (an experience involving the perception of something not present)
- Anaphylactic reaction (serious allergic reaction)
- Multi-organ failure (multisystem organ failure)
- Renal failure (kidney dysfunction)
- Abdominal pain
- Depressed level of consciousness
- Hyperbilirubinaemia (excess of bilirubin in the blood)
- Blood bilirubin increased
40-49:
- Suicidal ideation
- Rash
- Urticaria (rash of round, red welts on the skin that itch intensely)
50-59:
- Sepsis (a severe blood infection that can lead to organ failure and death)
60+:
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Renal tubular necrosis (death of kidney tubules)
- Cardiac failure congestive
- Fluid overload (too much fluid in the blood)
- Fungal infection
- Ileus (a painful obstruction of the ileum or other part of the intestine)
- Infection
- Pleural effusion (water on the lungs)
- Pulmonary oedema (fluid accumulation in the lungs)
- Respiratory disorder (respiratory disease)
What are the existing conditions these people have? *
- Fungal Infection: 5 people, 17.24%
- Fever: 5 people, 17.24%
- Pain: 5 people, 17.24%
- Nausea (feeling of having an urge to vomit): 4 people, 13.79%
- Insomnia (sleeplessness): 4 people, 13.79%
- Constipation: 3 people, 10.34%
- Wheezing (a high-pitched whistling sound made while you breath): 3 people, 10.34%
- Oral Pain: 3 people, 10.34%
- Abdominal Distension: 3 people, 10.34%
- Stress And Anxiety: 3 people, 10.34%
* Approximation only. Some reports may have incomplete information.
Do you take Mycostatin and Solu-cortef?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Mycostatin (4,144 reports)
- Solu-cortef (7,983 reports)
Browse all drug interactions of Mycostatin and Solu-cortef:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Mycostatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Solu-cortef:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mycostatin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Solu-cortef and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on nystatin and hydrocortisone sodium succinate (the active ingredients of Mycostatin and Solu-cortef, respectively), and Mycostatin and Solu-cortef (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Sandimmune cause Cataract? - 7 seconds ago
- Acute Myocardial Infarction and Flushing Aggravated - 39 seconds ago
- Drug interactions of Citalopram Hydrobromide and Nystatin - 43 seconds ago
- Could Hydrocortisone cause Hypokalemia? - 50 seconds ago
- Hctz and Oedema Aggravated for Women aged 60+ - 51 seconds ago
- Cystic Fibrosis and drugs of ingredients of escitalopram oxalate - 57 seconds ago
- Drug interactions of Metoprolol Succinate and Xermelo - a minute ago
- Sinemet and Hypokalemic Syndrome for Women aged 60+ - a minute ago
- Sinemet and Hypokalaemic Syndrome for Women aged 60+ - a minute ago
- Sinemet and Hypopotassemia for Women aged 60+ - a minute ago